文献速递心脑血管急症

区域协同救治体系对ST段抬高型心肌梗死救治时间及短期预后的影响

[Effect of regional synergistic treatment system on the treatment time and short-term prognosis of ST-segment elevation myocardial infarction].
PubMed 文献 · Zhonghua Wei Zhong Bing Ji Jiu Yi Xue · 2017-01-01
一句话结论区域协同救治体系建立后,STEMI患者S2B、FMC2B、D2B时间缩短,90天心衰、全因死亡及其他相关不良事件发生率降低。

该研究回顾性分析2013年1月至2017年1月就诊于上海交通大学医学院附属苏州九龙医院急诊中心并接受直接经皮冠状动脉介入治疗(PPCI)的STEMI患者临床数据。按急性胸痛区域协同救治体系建立前后分为A组(2013年1月至2014年12月,83例)和B组(2015年1月至2017年1月,138例),比较S2B、FMC2B、D2B时间及90天终点事件。结果显示B组S2B、FMC2B、D2B时间均较A组显著缩短(均P<0.05),90天心力衰竭、全因死亡、其他相关不良事件发生率均显著降低(均P<0.05)。多因素Logistic回归分析显示,建立急性胸痛区域协同救治体系可降低90天终点事件发生率。

要点

  • B组D2B时间66(62,70)分钟,较A组85(72,99)分钟显著缩短(P<0.05)。
  • B组90天全因死亡发生率1.4%,低于A组7.2%(P<0.05)。
  • B组90天心力衰竭发生率20.3%,低于A组32.5%(P<0.05)。
  • B组90天其他相关不良事件发生率23.2%,低于A组36.1%(P<0.05)。
  • 多因素Logistic回归显示建立区域协同救治体系可降低90天终点事件发生率(其他相关不良事件OR=1.925,95%CI 1.049-3.530,P=0.034)。

适用人群与场景

  • 2013年1月至2017年1月就诊于上海交通大学医学院附属苏州九龙医院急诊中心并接受PPCI的STEMI患者,共221例。
  • A组为急性胸痛区域协同救治体系建立前(2013年1月至2014年12月)接受PPCI的患者,83例。
  • B组为区域协同救治体系建立后(2015年1月至2017年1月)接受治疗的患者,138例。

研究设计与关键结果

  • 研究类型为回顾性分析,纳入221例接受PPCI的STEMI患者,A组83例、B组138例。
  • 与A组相比,B组S2B时间180(140,210)分钟vs 201(154,225)分钟、FMC2B时间89(78,100)分钟vs 94(83,107)分钟、D2B时间66(62,70)分钟vs 85(72,99)分钟均显著缩短(均P<0.05)。
  • 与A组相比,B组90天心力衰竭发生率20.3% vs 32.5%、全因死亡发生率1.4% vs 7.2%、其他相关不良事件发生率23.2% vs 36.1%均显著降低(均P<0.05)。
  • 多因素Logistic回归分析显示,建立急性胸痛区域协同救治体系可降低90天终点事件发生率:心力衰竭OR=1.904(95%CI 0.968-1.004,P=0.048),全因死亡OR=11.724(95%CI 0.955-1.048,P=0.013),其他相关不良事件OR=1.925(95%CI 1.049-3.530,P=0.034)。

证据类型、等级与局限

  • 证据类型:回顾性分析。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为,建设区域协同救治体系可缩短STEMI患者急救救治时间,并降低包括心力衰竭和死亡在内的90天终点事件发生率。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

OBJECTIVE: To explore the effect of regional synergistic treatment system on the treatment time and short-term prognosis of patients with ST-segment elevation myocardial infarction (STEMI).

METHODS: A retrospective analysis of the clinical data of STEMI patients who admitted to emergency center of Suzhou Kowloon Hospital Affiliated to Shanghai Jiaotong University School of Medicine and underwent primary percutaneous coronary intervention (PPCI) from January 2013 to January 2017 were conducted. All patients were divided into two groups, group A was the patients who underwent the PPCI before the establishment of the acute chest pain area co-treatment system (from January 2013 to December 2014), and group B was the patients who received the treatment after the establishment of the area co-treatment system (from January 2015 to January 2017). The length of time from onset of symptoms to the balloon dilatation (S2B), the length of time from the first medical contact to the balloon dilatation (FMC2B), the length of time from entering the gate of hospital to the balloon dilatation (D2B), and the incidence of 90-day end point events (including heart failure, all-cause death, and other related adverse events) were collected. The relations of the establishment of the acute chest pain area co-treatment system and the incidence of 90-day end point events were analyzed by multivariable Logistic regression analysis.

RESULTS: Among the 221 enrolled patients with STEMI, 83 patients were in group A and 138 patients were in group B respectively. Compared with group A, S2B time [minutes: 180 (140, 210) vs. 201 (154, 225)], FMC2B time [minutes: 89 (78, 100) vs. 94 (83, 107)] and D2B time [minutes: 66 (62, 70) vs. 85 (72, 99)] were significantly shortened in group B (all P < 0.05), the incidence of 90-day end point events were significantly decreased (heart failure: 20.3% vs. 32.5%, all-cause death: 1.4% vs. 7.2%, other related adverse events: 23.2% vs. 36.1%, all P < 0.05). It was shown by multivariable Logistic regression analysis that the establishment of the acute chest pain area co-treatment system could lower the incidence of 90-day end point events [heart failure: odds ratio (OR) = 1.904, 95% confidence interval (95%CI) = 0.968-1.004, P = 0.048; all-cause death: OR = 11.724, 95%CI = 0.955-1.048, P = 0.013; other related adverse events: OR = 1.925, 95%CI = 1.049-3.530, P = 0.034].

CONCLUSIONS: The construction of regional synergistic treatment system can shorten the emergency treatment time of STEMI patients and reduce the incidence of 90-day end point events including heart failure and death.

来源:Zhonghua Wei Zhong Bing Ji Jiu Yi Xue,查看原文。版权归原作者所有。

参考来源

  1. Zhang G, Li C, Li H, et al. [Effect of regional synergistic treatment system on the treatment time and short-term prognosis of ST-segment elevation myocardial infarction]. Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2017. PMID: 29017645. doi:10.3760/cma.j.issn.2095-4352.2017.10.003

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。